1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  
February 2018  
March 2018  
April 2018  
May 2018  
June 2018  
July 2018  
August 2018  
September 2018  
October 2018  
November 2018  
December 2018  
January 2019  
February 2019  
March 2019  
April 2019  
May 2019  
June 2019  
July 2019  
August 2019  
September 2019  
October 2019  
November 2019  
December 2019  
January 2020  
February 2020  
March 2020  
April 2020  
May 2020  
June 2020  
July 2020  
August 2020  
September 2020  
October 2020  
November 2020  
December 2020  
January 2021  
February 2021  
March 2021  
April 2021  
May 2021  
June 2021  
July 2021  
August 2021  
September 2021  
October 2021  
November 2021  
December 2021  
January 2022  
February 2022  
March 2022  
April 2022  
May 2022  
June 2022  
July 2022  
August 2022  
September 2022  
October 2022  
November 2022  
December 2022  
January 2023  
February 2023  
March 2023  
April 2023  
May 2023  
June 2023  
July 2023  
August 2023  
September 2023  
October 2023  
November 2023  
December 2023  
January 2024  
February 2024  
March 2024  

This page is powered by Blogger. Isn't yours?

Monday, June 13, 2016

 

Alzheimer’s Medications







































Image Source: LESNOUNOUSMOBILES

Most people know that Alzheimer’s disease (AD) leads to memory loss and cognitive decline. Most people, however, may not know that many people with AD also suffer with serious behavioral issues. According to the National Institutes of Health (NIH), “Approximately 30% to 90% of patients with dementia suffer from behavioral disorders. They include symptoms such as depression, anxiety psychosis, agitation, aggression, disinhibition, and sleep disturbances.”

People diagnosed with Alzheimer’s disease are usually given one of the five medications approved by the FDA to “treat” loss of memory and cognition... but none are significantly effective. The 2012 “Best Buy Drugs Report” issued by Consumers Union was not given much publicity until excerpts appeared in The Washington Post on January 7, 2013. Consumers Union reviewed more than 1100 research studies and articles on AD meds, and began the recommendations section of their comprehensive report with this statement: “The medications used to treat mental decline in people with Alzheimer’s disease are not particularly effective. When compared to a placebo, most people who take one will not experience a meaningful benefit.”

The Research Center of the Alzheimer’s Association reports similar dismal results. “On average, the five (FDA) approved Alzheimer’s drugs are effective for about six-12 months for about half of the individuals who take them.” The comprehensive “Alzheimer’s Disease Progress Report” issued by NIH is only slightly more optimistic. NIH concluded that the five FDA approved AD meds “may help some people”... but even for those helped by these meds, it is “only for months to a couple of years.”

Unfortunately, many doctors are either ignorant of this research or are not being completely honest with their AD patients and caregivers when they continue to prescribe these expensive but ineffective medications year after year. Money spent on these costly ineffective medications might be better spent on day care programs, home companions, or health aides if doctors shared this research with their patients and caregivers.

A May 30, 2016 Time Magazine article noted that “Americans with Alzheimer’s disease each incur an estimated $35,000 in medication costs annually.” That is a huge amount of money spent on medication to treat Alzheimer’s and other health issues, an amount grossly inflated by money spent on medication that has no effect on their AD.

AD patients with psychiatric conditions are not much better off. According to the Alzheimer’s Association, “When considering use of medications, it is important to understand that no drugs are specifically approved by the U.S. Food and Drug Administration (FDA) to treat behavioral and psychiatric dementia symptoms.”

Because anti-anxiety medications currently given to people with AD do not work effectively or only work effectively for a brief period of time, many AD patients are given powerful anti-psychotic medications. These medications come with box warnings specifically stating that they should not be given to people with dementia because of the greater risk of serious negative side effects. However, when no other medication seems to help, doctors often try these heavy duty meds anyway, hoping for a better treatment outcome.

Pharmaceutical companies are currently investing huge sums of money hoping to discover medication that will prevent, effectively treat, or significantly slow down the rate of cognitive decline for those with AD. I wish them success. However, I hope that pharmaceutical companies are also investing huge sums of money to discover medication that can effectively treat severe anxiety and other psychiatric issues affecting so many patients with AD.

Worsening psychiatric issues can lessen the quality of life for many loved ones with AD even more than their worsening cognitive deficits. As a former spouse caregiver, I can attest to the fact that my wife’s psychiatric disorders greatly diminished the quality of her life, particularly in her last year. Despite a three week stay in a psychiatric hospital, doctors were never able to find any medication to properly treat her severe anxiety and agitation.

Story Source: The above story is based on materials provided by HUFFINGTONPOST
Note: Materials may be edited for content and length